期刊文献+

Src激酶抑制剂PP2对人胃癌细胞生物学行为的影响 被引量:6

The effect of Src kinase inhibitor PP2 on the biological behaviors of human gastric carcinoma SGC-7901 cells
原文传递
导出
摘要 目的:探讨Src激酶抑制剂PP2对人胃癌SGC-7901细胞生长、迁移、侵袭和诱导血管形成等生物学行为的影响。方法:通过Western印迹法检测PP2作用对SGC-7901细胞中Src激酶活化的影响;分别采用MTT法、划痕实验、Transwell小室法和体外诱导血管形成分析实验观察PP2对SGC-7901细胞生长、迁移、基质侵袭和诱导血管形成等生物学行为的影响。结果:MTT法检测结果提示,15μmol/L PP2作用人胃癌SGC-7901细胞12 h时能明显抑制细胞的增殖;5和10μmol/L PP2均能抑制SGC-7901细胞的迁移、侵袭和诱导血管的形成,且其抑制能力随PP2浓度的增加而逐渐增强。结论:Src激酶抑制剂PP2具有抑制人胃癌SGC-7901细胞生长、迁移、侵袭和诱导血管形成的能力,可能对胃癌具有一定的治疗效果。 Objective:To investigate the effect of Src kinase inhibitor PP2 on the growth,migration,invasion,and angiogenesis capabilities of human gastric carcinoma cell line SGC-7901.Methods:Western blotting was used to detect the effect of Src inhibitor PP2 on Src activation.MTT assay,wound-healing assay,Transwell chamber,and angiogenesis in vitro assay were performed to detect the effects of Src inhibitor PP2 on the growth,migration,invasion and angiogenesis of human gastric carcinoma cell line SGC-7901,respectively.Results:MTT assay showed that the proliferation of human gastric carcinoma SGC-7901 cells was significantly inhibited after co-culture with 15 μmol/L PP2 for 12 h.PP2 inhibited the migration,invasion,and angiogenesis of human gastric carcinoma cells at 5 and 10 μmol/L in a concentration-dependent manner.Conclusion:Src inhibitor PP2 inhibited the growth,migration,invasion and angiogenesis capabilities of human gastric carcinoma cell line SGC-7901 in vitro.Src inhibitor may be effective in the treatment of gastric carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2010年第10期822-826,共5页 Tumor
基金 国家自然科学基金资助项目(编号:30660065) 教育部春晖计划资助项目(编号:Z2007-1-01003) 博士科研启动金资助项目(编号:NY2006BQ006)
  • 相关文献

参考文献2

二级参考文献25

  • 1甄林林,朱旬,郑伟,王萱仪,武正炎.Tyrphostins AG1478对内分泌耐药乳腺癌细胞的作用[J].南京医科大学学报(自然科学版),2006,26(7):530-533. 被引量:1
  • 2BROWNE B C,O'BRIEN N,DUFFY M J,et al.HER-2 signaling and inhibition in breast cancer[J].Curr Cancer Drug Targets,2009,9(3):419-438. 被引量:1
  • 3JONE K L,BUZDAR A U.Evolving novel anti-HER2 strategies[J].Lancet Oncol,2009,10(12):1179-1187. 被引量:1
  • 4CHAN C T,METZ M Z,KANE S E.Differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor(EGFR) kinase inhibitors[J].Breast Cancer Res Treat,2005,91(2):187-201. 被引量:1
  • 5MODJTAHEDI H,ESSAPEN S.Epidermal growth factor receptor inhibitors in cancer treatment:advances,challenges and opportunities[J].Anticancer Drugs,2009,20(10):851-855. 被引量:1
  • 6DITTMANN K,MAYER C,RODEMANN H P.Nuclear EGFR as novel therapeutic target:insights into nuclear translocation and function[J].Strahlenther Onkol,2010,186(1):1-6. 被引量:1
  • 7LO H W,XIA W,WEI Y,et al.Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer[J].Cancer Res,2005,65(1):338-348. 被引量:1
  • 8TEVAARWERK A J,KOLESAR J M.Lapatinib:a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer[J].Clin Ther,2009,31(2):2332-2348. 被引量:1
  • 9SHUSHAN A,ROJANSKY N,LAUFER N,et al.The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth[J].Human Reprod,2004,19(9):1957-1967. 被引量:1
  • 10ZHANG Y G,DU Q,FANG W G,et al.Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells[J].Int J Oncol,2008,33(3):595-602. 被引量:1

共引文献11

同被引文献121

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部